Under the chairmanship of Dr. G. N. Singh, Drug Controller General of India, a meeting of associations allied with the pharmaceutical sector was organised to discuss the measures to streamline the drug regulatory system as well as to ensure Quality, Safety & Efficacy of drugs manufactured in the country. The meeting was held at FDA Bhavan, CDSCO Headquarters on 14th November' 2017. Apart from OPPI, IDMA, IPA and other association of human pharma, INFAH represented the Animal Health pharmaceutical and biological sector. Dr. Niraj Warke, Dr. E. Shankaraiah and Dr. Nitin Bhatia represented INFAH. The discussions were oriented towards the GSR 429 (E) for stability studies for pharmaceuticals products and to synchronize Schedule M on par with WHO-GMP.